Morey L. Smith

6.6k citations

29 papers · 1.3k indexed · h-index 15

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
Genetics top 10%
- Chronic Lymphocytic Leukemia Research

Papers in

Genetics 6
- Chronic Lymphocytic Leukemia Research 6
Hematology 6
- Platelet Disorders and Treatments 3

Co-authors: Stephen K. Tahir James M. Trevillyan Paul Nimmer Karl W. Mollison Steven W. Elmore Stevan W. Djurić Joel Johansson Yung‐Wu Chen
Journals: Blood (6 papers)Cellular Immunology (2 papers)Molecular Cancer Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

Morey L. Smith

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Morey L. Smith

Since Specialization

Citations

This map shows the geographic impact of Morey L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morey L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morey L. Smith more than expected).

Fields of papers citing papers by Morey L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morey L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morey L. Smith. The network helps show where Morey L. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Morey L. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Morey L. Smith Line = papers co-authored together Morey L. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia Blood ·Stephen K. Tahir, Emiliano Calvo, Benedito A. Carneiro, Junichiro Yuda, Aditya Shreenivas, Mojca Jongen‐Lavrencic, Eelke Gort, Kenichi Ishizawa, Daniel Morillo, Anna Rusin, Morey L. Smith, Cheng Dong, Monica Motwani, David Sharon, Tamar Uziel, Dimple Modi, Fritz G. Buchanan, Susan E. Morgan-Lappe, Bruno C. Medeiros, Darren C. Phillips	2023	9
2	Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors Cancer Research ·Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Xiao Yu, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, D. L. Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico L. DiGiammarino, Xin Lü, Nandini Rudra-Ganguly, Bruce A. Trela, Susan E. Morgan-Lappe	2021	32
3	Quantification of BCL-2 Family Members by Flow Cytometry Methods in molecular biology ·Morey L. Smith, Stephen K. Tahir	2018	1
4	Abbv-621 Is a Novel and Potent TRAIL Receptor Agonist Fusion Protein That Induces Apoptosis Alone and in Combination with Navitoclax and Venetoclax in Hematological Tumors Blood ·Stephen K. Tahir, Morey L. Smith, Larry R. Solomon, Haichao Zhang, John Xue, Xiao Yu, Dong Cheng, Jincheng Song, Susan E. Morgan-Lappe, Darren C. Phillips	2017	8
5	Potential mechanisms of resistance to venetoclax and strategies to circumvent it BMC Cancer ·Stephen K. Tahir, Morey L. Smith, Paul Hessler, Matthew Kurniawan, Kenneth B. Idler, Chang H. Park, Joel Johansson, Lloyd T. Lam	2017	142
6	CDK9 Inhibition Reverses Resistance to ABT-199 (GDC-0199) By Down-Regulating MCL-1 Blood ·Jun Chen, Sha Jin, Paul Tapang, Stephen K. Tahir, Morey L. Smith, John Xue, Haichao Zhang, Wenqing Gao, Yunsong Tong, Richard J. Clark, Justin L. Ricker, Thomas D. Penning, Daniel H. Albert, Darren C. Phillips, Andrew J. Souers, Joel Johansson	2014	1
7	The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo Molecular Cancer Therapeutics ·Jun Chen, Sha Jin, Myriam Steinback, Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel Johansson, Chris Tse, Steven W. Elmore	2011	119
8	Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity Journal of Medicinal Chemistry ·Brad E. Sleebs, Peter E. Czabotar, Wayne J. Fairbrother, W. Douglas Fairlie, John A. Flygare, David C.S. Huang, Wilhelmus J. A. Kersten, Michael F. T. Koehler, Guillaume Lessène, Kym N. Lowes, John P. Parisot, Brian J. Smith, Morey L. Smith, Andrew J. Souers, Ian P. Street, Hong Yang, Jonathan B. Baell	2011	60
9	Bcl-2 family proteins are essential for platelet survival Cell Death and Differentiation ·Yang Wang, Paul Nimmer, Lacy Davidson Ferguson, Lanna SONG, Ryan M. Fryer, D. Elsarnagawy, Laurie Iciek, S. J. Morgan, Yao Shi, Randy Nelson, Lee C. Preusser, Glenn A. Reinhart, Morey L. Smith, S.H. Rosenberg, Steven W. Elmore, Christin Tse	2007	335
10	Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression Journal of Cardiovascular Pharmacology ·Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets, Tomio Inukai, James M. Trevillyan, Sandra E. Burke, Muhamad Riyadi Putra, Agnes Y. Song, Rolf Wagner, Joy Bauch, Kennan Marsh, Thomas A. Fey, Gin C. Hsieh, Donna M. Gauvin, Karl W. Mollison, George W. Carter, Stevan W. Djurić	2007	55
11	Bcl-2 Family Protein Inhibitors Induce a Unique Thrombocytopenia In Vivo. Blood ·Steven W. Elmore, Joy Bauch, Ryan M. Fryer, Laurie Iciek, Kennan C. Marsh, Sherry J. Morgan, Richard Alan Nelson, Glenn A. Reinhart, Morey L. Smith, Chris Tse, Saul H. Rosenberg	2006	2
12	T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC Cellular Immunology ·Deanna L. Haasch, Yung‐Wu Chen, Regina M. Reilly, X. Grace Chiou, Sandra Koterski, Morey L. Smith, Paul Kroeger, Alfred Hardy, Donald N. Halbert, Karl W. Mollison, Stevan W. Djurić, James M. Trevillyan	2002	167
13	TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators Cellular Immunology ·Lotta Loerbroks, Morey L. Smith, Ann Roseela J, Stephen J. Ballaron, Michael P. Sheets, Earl J. Gubbins, Usha Warrior, Julie A. Wilkins, Carol S. Surowy, Masaki Nakane, George W. Carter, James M. Trevillyan, Karl W. Mollison, Stevan W. Djurić	2002	27
14	Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds Journal of Biological Chemistry ·James M. Trevillyan, X. Grace Chiou, Yung‐Wu Chen, Stephen J. Ballaron, Michael P. Sheets, Morey L. Smith, Paul E. Wiedeman, Usha Warrior, Julie A. Wilkins, Earl J. Gubbins, Gerard D. Gagné, Jane A. Fagerland, George W. Carter, Jay R. Luly, Karl W. Mollison, Stevan W. Djurić	2001	85
15	Antifungal rapamycin analogues with reduced immunosuppressive activity Bioorganic & Medicinal Chemistry Letters ·Daniel A. Dickman, Hong Ding, Qun Li, Angela M. Nilius, Akbar Ade Firmansyah, Stephen J. Ballaron, James M. Trevillyan, Morey L. Smith, 鹿轶红, Ki H. Kim, Aparna V. Sarthy, Robert C. Goldman, Jacob J. Plattner, Youssef L. Bennani	2000	14
16	A Macrolactam Inhibitor of T Helper Type 1 and T Helper Type 2 Cytokine Biosynthesis for Topical Treatment of Inflammatory Skin Diseases1 Journal of Investigative Dermatology ·Karl W. Mollison, Thomas A. Fey, Donna M. Gauvin, J Ruhnke, Michael P. Sheets, Morey L. Smith, Frederick Van Fleteren, Nikolaos M. Nikolaidis, Benjamin C. Lane, James M. Trevillyan, George W. Carter, Dórea Filho, Lotta Loerbroks, Giulia Di Rosa, John Cannon, Kennan C. Marsh, Jay R. Luly	1999	10
17	Ex VivoAssessment of Immunosuppression in Undiluted Whole Blood from Pigs Dosed with Tacrolimus (FK506) Clinical Immunology ·Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets, Stephen J. Ballaron, James M. Trevillyan, Thomas A. Fey, Donna M. Gauvin, J Ruhnke, Frederick Van Fleteren, Gin C. Hsieh, Joy Bauch, Kennan C. Marsh, George Carter, Jay R. Luly, Stevan W. Djurić, Karl W. Mollison	1999	3
18	Inhibition of p56lckTyrosine Kinase by Isothiazolones Archives of Biochemistry and Biophysics ·James M. Trevillyan, X. Grace Chiou, Stephen J. Ballaron, Oli Charbonneau, Alex Buko, Michael P. Sheets, Morey L. Smith, Chinenye Iwuji, Paul E. Wiedeman, Noah P. Tu, David J. Madar, Juharni, Earl J. Gubbins, Usha Warrior, Yung‐Wu Chen, Karl W. Mollison, Connie R. Faltynek, Stevan W. Djurić	1999	28
19	Psychosocial correlates of immune responsiveness and illness episodes in us air force academy cadets undergoing basic cadet training Journal of Psychosomatic Research ·David Lee, Richard T. Meehan, Christine C. Robinson, Morey L. Smith, Bala	1995	10
20	Infectious Disease Risks Associated with Exposure to Stressful Environments SAE technical papers on CD-ROM/SAE technical paper series ·Richard T. Meehan, Morey L. Smith, Clarence F. Sams	1993	2

About Morey L. Smith

Morey L. Smith is a scholar working on Genetics, Hematology, Immunology, Speech and Hearing and Toxicology, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (4 papers), Signaling Pathways in Disease (4 papers), Phagocytosis and Immune Regulation (4 papers), CAR-T cell therapy research (3 papers), Platelet Disorders and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Hematology (213 citations), Genetics (148 citations), Cancer Research (184 citations), Toxicology (38 citations) and Molecular Biology (701 citations). Morey L. Smith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Stephen K. Tahir, James M. Trevillyan, Paul Nimmer, Karl W. Mollison, Steven W. Elmore, Stevan W. Djurić, Joel Johansson, Yung‐Wu Chen, Glenn A. Reinhart and Christin Tse. Their work appears in journals such as Blood, Cellular Immunology, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact